OncoCyte Revenue

In the year 2024, OncoCyte had annual revenue of $1.88M USD with 25.15% growth. OncoCyte had revenue of $1.49M in the quarter ending December 31, 2024, with 373.25% growth.

Revenue

$1.88M

Revenue Growth

+25.15%

P/S Ratio

49.20

Revenue / Employee

$38.39K

Employees

Market Cap

73.92M GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.88M	378.00K	25.15%
Dec 31, 2023	1.50M	545.00K	56.89%
Dec 31, 2022	958.00K	-1.24M	-56.41%
Dec 31, 2021	2.20M	982.00K	80.76%
Dec 31, 2020	1.22M	-	-
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
AstraZeneca	43.19B
GSK plc	31.38B
Haleon	11.23B
Smith & Nephew	4.64B
ConvaTec Group	1.83B
Hikma Pharmaceuticals	2.50B
HUTCHMED (China)	503.39M
Oxford Nanopore Technologies	183.19M

Revenue Rankings

OncoCyte News

4 weeks ago - OncoCyte a new buy at Lake Street on transplant rejection testing - Seeking Alpha
4 weeks ago - Oncocyte targets $20M in recurring revenue from 20 transplant centers by 2025 - Seeking Alpha
4 weeks ago - OncoCyte Corporation (OCX) Q4 2024 Earnings Call Transcript - Seeking Alpha
4 weeks ago - OncoCyte Corporation 2024 Q4 - Results - Earnings Call Presentation - Seeking Alpha
4 weeks ago - OncoCyte GAAP EPS of -$1.93, revenue of $1.49M - Seeking Alpha
5 weeks ago - OncoCyte FY Earnings Preview - Seeking Alpha
5 weeks ago - Oncocyte to Release Fourth Quarter 2024 Results on March 24, 2025 - GlobeNewsWire
2 months ago - AWM Investment Company, Inc. Increases Stake in OncoCyte Corp - GuruFocus

More News